Acticor Biotech, Hemerion and Vivet Therapeutics, winners of the Galien Medstartup Awards 2021: great recognition of French excellence in scientific innovation
NEW YORK, Oct. 29, 2021 /PRNewswire/ — Business France and the Galien Foundation are pleased to announce the winners of the eighth edition of the Galien Medstartup Awards. This award, granted during the United States Galien awards ceremony, brings a prestigious panel to the table. This year again, the most influential stakeholders in the pharmaceutical industry were able to gather and discuss new collaborative opportunities in medical innovation, strengthening Franco-American relationships.
WINNERS OF THE 2021 GALIEN MEDSTARTUP AWARDS
BEST COLLABORATION IN THE PHARMACEUTICAL OR BIOTECHNOLOGY INDUSTRY
Acticor Biotech in partnership with the Memorial Hermann Texas Medical Center
Acticor Biotech collaborates with the Memorial Hermann Texas Medical Center to launch and conduct the ACTISAVE USA clinical trial and evaluate the efficacy of Glenzocimab in patients suffering from acute ischemic stroke.
BEST COLLABORATION IN THE MEDTECH OR DIGITAL HEALTH SECTOR
Hemerion in partnership with Mount Sinai Health System (MSHS)
Hemerion and Mount Sinai Health System (MSHS) work together on the development of surgical neurooncology to deliver the first ever photodynamic therapy to manage newly diagnosed Glioblastoma (GBM) – one of the most common and devastating malignant primary brain tumors.
BEST COLLABORATION FOR THE DEVELOPING OR UNDERSERVICED POPULATIONS WORLDWIDE
Vivet Therapeutics in partnership with Pfizer and Mirum Pharmaceuticals
Vivet Therapeutics works with two US leaders in their field, Pfizer and Mirum Pharmaceuticals, to develop novel gene therapy treatments and technologies for rare, inherited metabolic diseases originating in the liver which are only currently cured by liver transplantation.
To access the replay of the ceremony: click here
Business France and the Galien Foundation took advantage of the vibrant energy surrounding the event to organize webinars and virtual networking sessions for 15 French startups and 250 pharma, biotech and medtech, American business leaders and investors.
MEDIA CONTACTS
Gwendoline Paquier – gwendoline.paquier@businessfrance.fr
Elodie Arnould – elodie.arnould@businessfrance.fr
French Healthcare is an innovative initiative aimed at bringing together French businesses, researchers and healthcare professionals to jointly promote their activities, expertise and technologies internationally. It helps promote the French vision for global health, based on a humanist approach to care and equitable and fair access to healthcare products and services. Business France, the national agency supporting the international development of the French economy, in partnership with the French Healthcare Association and the Ministry for Europe and Foreign Affairs, is responsible for promoting the brand, which aims to coordinate a team approach to stimulate international cooperation and the influence of France’s key strengths.
Follow French Healthcare:
#FrenchHealthcare
Website: www.frenchhealthcare.fr
Twitter: https://twitter.com/FrHealthCare_EN @FrHealthCare_EN
LinkedIn: https://www.linkedin.com/company/french-healthcare-en/
Youtube: https://www.youtube.com/playlist?list=PLsMLWBGsp3ap17paTV9KcY3meoBZTxWn5
Choose France is a registered trademark of the French government that promotes France’s economic attractiveness internationally.
#ChooseFrance
Business France is the national agency supporting the international development of the French economy, responsible for fostering export growth by French businesses, as well as promoting and facilitating international investment in France. It promotes France’s companies, business image and nationwide attractiveness as an investment location, and also runs the VIE international internship program. Business France has 1,500 personnel, both in France and in 55 countries throughout the world, who work with a network of partners. Since January 2019, as part of the reform of the state support system for exports, Business France has given private partners responsibility for supporting French SMEs and mid-size companies in the following markets: Belgium, Hungary, Morocco, Norway, the Philippines and Singapore.
For further information, please visit www.businessfrance.fr
The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation that improves the state of human health. Its mission is to serve as a vehicle for the open exchange of ideas that drive science and new innovations. Its vision is to catalyze the development of the next generation of innovative treatment and technologies that will improve health and save lives. Its scope is global, and their commitment to progress in medicine is both measurable and concrete. Its members express this through the establishment of productive relationships to build lasting bridges between the commercial research enterprise and local communities engaged in public policy, science, finance, academic research and the media. The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements in improving the global human condition through the development of innovative therapies. The Prix Galien was created in France in 1970 in honor of Claude Galien, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical and medical technology research.
For more information, please visit www.galienfoundation.org
View original content to download multimedia:https://www.prnewswire.com/news-releases/acticor-biotech-hemerion-and-vivet-therapeutics-winners-of-the-galien-medstartup-awards-2021-great-recognition-of-french-excellence-in-scientific-innovation-301411924.html
SOURCE Business France
